摘要
目的探讨急性心肌梗死早期应用门冬氨酸钾镁对溶栓后室性心律失常临床效果的影响。方法选取在我院接受治疗的急性心肌梗死患者108例,随机将所有患者分为治疗组56例和对照组52例。两组患者均进行溶栓治疗,在结合常规治疗的同时,治疗组给予门冬氨酸钾镁,对照组给予左卡尼丁,并观察两种药物对患者室性心律失常的影响。结果治疗结束后,对照组恶性室性心律失常发生率为38.5%;治疗组恶性室性心律失常发生率为16.1%,两组恶性室性心律失常发生率比较,差异显著,具有统计学意义(P<0.05)。结论急性心肌梗采用门冬氨酸钾镁进行治疗能明显减少死于溶栓治疗后恶性室性心律失常的发生,具有临床应用价值。
Objective To investigate the therapeutic effect of potassium magnesium aspartate on ventricular arrhythmia after thrombolysis in early acute myocardial infarction. Methods A total of 108 cases of acute myocardial infarction who received therapy in our hospital were randomly divided into treatment group （n = 56） and control group （n = 52）. Both group received thrombolysis. In addition to routine treatment, potassium magnesium aspartate was administered to the treatment group, and L-carnitine was administered to the control group. The therapeutic effects of the two drugs on ventricular arrhythmia were observed. Results The incidence rate of malignant ventricular arrhythmia was significantly lower in the control group than in the treatment group （16.1% vs 38.5%, P〈0.05）. Conclusion Potassium magnesium aspartate can significantly decrease the incidence of deaths from malignant ventricular arrhythmia after thrombolvsis in the treatment of acute myocardial infarction.
出处
《心血管病防治知识（学术版）》
2012年第5期34-35,共2页
Prevention and Treatment of Cardiovascular Disease
关键词
急性期
心肌梗死
室性心律失常
门冬氨酸钾镁
Acute
Myocardial infraction
Ventricular arrhythmia
Potassium magnesium aspartate
